Atika Capital Management’s Zura Bio ZURA Stock Holding History

Atika Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-276,000	Closed	-$1.2M	–	116
2025 Q3	$1.2M	Buy	+276,000	New	+$496K	0.1%	82

Other funds holding ZURA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Atika Capital Management's ZURA Position: Q4 2025 in Review

Atika Capital Management sold out of Zura Bio (ZURA) in Q4 2025, closing a stake of 276,000 shares — an estimated $1.2M sold.

Atika Capital Management first reported a position in ZURA in Q3 2025 and held it in 1 quarter. The position peaked at $1.2M in Q3 2025. 75 funds tracked by Wall St. Rank hold ZURA as of Q4 2025.

Atika Capital Management reported no remaining Zura Bio position as of Q4 2025 after selling out during the quarter.
Atika Capital Management sold 276,000 Zura Bio shares in Q4 2025, an estimated $1.2M.
Atika Capital Management first reported a position in Zura Bio in Q3 2025 and held it in 1 quarter.
Atika Capital Management's Zura Bio position peaked at $1.2M in Q3 2025.
75 funds tracked by Wall St. Rank held Zura Bio as of Q4 2025.

Based on Atika Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.